Gift of Life Biologics Inc., a Boca Raton, FL-based vertically integrated supplier of allogeneic cellular starting material to the biopharmaceutical industry, closed a $6m seed financing round.
The company is backed by the Gift of Life Marrow Registry, an organization recruiting, qualifying and collecting cellular products from volunteer donors. Its donor registry is accredited by the World Marrow Donor Association (WMDA), its apheresis center is accredited by the Association for the Advancement of Blood & Biotherapies (AABB) and its cellular therapy laboratory’s moderate and high complexity testing services are CLIA accredited.
Led by Stephen B. Siegel, Chairman of the Board, Gift of Life Biologics is the source for cell and gene therapy developers needing GMP-compliant starting material to power their R&D and commercialization needs.
The company operates a vertically integrated, 32,000 sq. ft. facility in South Florida including a donor center, high capacity apheresis collection facility and cellular therapy laboratory and biobank.
Commercialization of initial cellular starting material products was effectuated in Q4 2021 while receipt of Institutional Review Board (IRB) approval for procurement of mononuclear cells and mobilized stem cells was done in Q4 2021 and Q1 2022.
FinSMEs
14/04/2022